New genetic test for baldness launched by HairDX
November 2008
PharmaGenoma, Inc. and its subsidiary HairDX, LLC have unveiled the
next generation of its genetic screening test for male pattern baldness.
Using the HairDX test, a physician can tell a man who tests positive
for the high risk genetic variant that he has approximately a 70% chance
of going bald. Similarly, a physician can tell a man who tests negative
for the high risk genetic variant that he has approximately a 70% chance
of not going bald.
“The next generation test report is based on a pooled data model from
multiple peer reviewed studies of over 2,000 Caucasian men. The studies
demonstrated the association between the genetic variants measured by
the HairDX genetic screening test and the development of Androgenetic
Alopecia in men,” says Andy Goren, HairDX Chairman and Co-Founder.
In addition to the improved clinical validity and utility, the HairDX
genetic test now includes genetic markers on the Androgen Receptor (AR)
gene as well as on Chromosome 20.
"A recent study demonstrated that Propecia, the only FDA approved
oral prescription medication for the treatment of male pattern baldness,
is effective at preventing hair loss over a period of several years.
Doctors using the HairDX genetic screening test can offer a treatment
plan to prevent hair loss in men of all ages before any visible signs of
hair loss," says Dr. Sharon Keene, Chief Medical Officer for HairDX and
former Chairman of the Annual Scientific Committee of the International
Society of Hair Restoration Surgeons.
Visible signs of hair loss usually mean that a man has already lost
up to 50% of their hair. Early detection via the HairDX genetic
screening test provides an opportunity for intervention and treatment
before it is too late.
The next generation screening test identifies approximately 70% of
men that will benefit from early treatment. As with any screening test,
some men will be identified for treatment even though they may not go
bald. Confirmatory tests by a qualified physician will eliminate
unnecessary treatment.
The HairDX test is available through qualified physicians’ offices in
the US.
Bookmark this page